Press Release / Media Release
Zydus receives final approval from the USFDA for Tamoxifen Citrate Tablets USP.28-10-2017
28-10-2017
Zydus Cadila gets USFDA approval to market Allopurinol tablets
The product will be manufactured at the group's formulations manufacturing facility at Baddi14-10-2017
Zydus Cadila gets USFDA nod for anti-depression drug
Zydus Cadila has received final approval from the US health regulator to market desvenlafaxine extended release tablets, used to treat depression. Approval from the United States Food and Drug...12-10-2017
Press Release / Media Release
Zydus receives final approval from the USFDA for Desvenlafaxine Extended-Release Tablets.12-10-2017
Board Meeting On November 14, 2017
We hereby inform that the meeting of the Board of Directors of the Company will be held on Tuesday, November 14, 2017 to consider apart from other agenda items to approve the unaudited financial results for the quarter / half year ended on September 30, 2017. Further, as per code of conduct for prevention of Insider Trading adopted by the Company under SEBI [Prohibition of Insider Trading] Regulations, 2015, the Trading Window will remain...11-10-2017
Compliance Certificate For The Half Year Ended On September 30, 2017.
Compliance Certificate for the half year ended on September 30, 2017.07-10-2017
Zydus Cadila gets US FDA nod to market anti-depressant drug
Drug firm Zydus Cadila has received final approval from the US health regulator to market Amitriptyline hydrochloride tablets used for treatment of depression in the American market. The company...07-10-2017
Certificate Of Practicing Company Secretary Under Regulation 40(10) Of The SEBI Listing Regulations, 2015 For The Half Year Ended On September 30, 2017.
Certificate of Practicing Company Secretary under Regulation 40(10) of the SEBI Listing Regulations, 2015 for the half year ended on September 30, 2017.07-10-2017
Statement Of Investor Complaints For The Quarter Ended On September 30, 2017.
Statement of investor complaints for the quarter ended on September 30, 2017.07-10-2017
Press Release / Media Release
Zydus receives final approval from the USFDA for Amitriptyline Hydrochloride Tablets USP.07-10-2017